Zhejiang Jolly Pharmaceutical Co. Ltd. | Ownership
Companies that own Zhejiang Jolly Pharmaceutical Co. Ltd.
Chang Xin Asset Management Co., Ltd.
20,225,974
4.33%
20,225,974
0.53%
07/17/2018
China Great Wall Asset Management Co., Ltd. (Invt Mgmt)
11,582,395
2.48%
11,582,395
0.37%
07/17/2018
Baoying Fund Management Co., Ltd.
1,705,700
0.37%
1,705,700
0.04%
12/31/2017
China Merchants Fund Management Co., Ltd.
673,243
0.14%
673,243
0.01%
06/30/2017
GF Fund Management Co., Ltd.
221,334
0.05%
20,300
0%
12/31/2017
Morgan Stanley Huaxin Fund Management Co., Ltd.
0
0%
-1,878,250
0%
12/31/2017
China Universal Asset Management Co., Ltd.
0
0%
-1,031,968
0%
12/31/2017
New China Fund Management Co., Ltd.
0
0%
-399,901
0%
12/31/2017
Hwabao WP Fund Management Co., Ltd.
0
0%
-6,800
0%
12/31/2017
China Southern Asset Management Co., Ltd.
0
0%
-266,400
0%
12/31/2017
| Address |
No. 388 Zhiyuan North Road
Huzhou Zhejiang 313200
China
|
|
Employees
|
- |
| Website |
- |
| Updated |
07/08/2019 |
| Zhejiang Jolly Pharmaceutical Co., Ltd. engages in the research & development, production and distribution of pharmaceuticals as well as Chinese herbal medicines. Its products include wuling powder, wuling capsule, linglianhua particle, clindamycin phosphate injection, doxapram injection, pefloxacin mesylate injection, azithromycin injection and sodium nitroprusside injection. The company was founded on January 28, 2000 and is headquartered Huzhou, China. |
